Author Archives: davidrcurry

Parents’ Willingness to Vaccinate Their Children With COVID-19 Vaccine: Results of a Survey in Italy

Posted on by

Journal of Adolescent Health
April 2022 Volume 70 Issue 4 p517-696
https://www.jahonline.org/current

 

Original Articles
Parents’ Willingness to Vaccinate Their Children With COVID-19 Vaccine: Results of a Survey in Italy
Gabriella Di Giuseppe, Concetta Paola Pelullo, Andrea Salvatore Volgare, Francesco Napolitano, Maria Pavia
Published online: January 17, 2022

Influence of Perceived Adolescent Vaccination Desire on Parent Decision for Adolescent COVID-19 Vaccination

Posted on by

Journal of Adolescent Health
April 2022 Volume 70 Issue 4 p517-696
https://www.jahonline.org/current

 

Influence of Perceived Adolescent Vaccination Desire on Parent Decision for Adolescent COVID-19 Vaccination
Jeanne R. Delgado, Peter G. Szilagyi, Jennifer Brazier Peralta,…Sitaram Vangala, Rashmi Shetgiri, Arie Kapteyn
Published online: January 18, 2022
p567-570

Widespread Use of Varicella Vaccine Does Not Reduce Immunity to Zoster of Others

Posted on by

Journal of Infectious Diseases
Volume 225, Issue 3, 1 February 2022
https://academic.oup.com/jid/issue/225/3

 

EDITORIAL COMMENTARY
Widespread Use of Varicella Vaccine Does Not Reduce Immunity to Zoster of Others
Anne A Gershon, Michael D Gershon
The Journal of Infectious Diseases, Volume 225, Issue 3, 1 February 2022, Pages 361–363, https://doi.org/10.1093/infdis/jiab501

Infants Younger Than 6 Months Infected With SARS-CoV-2 Show the Highest Respiratory Viral Loads

Posted on by

Journal of Infectious Diseases
Volume 225, Issue 3, 1 February 2022
https://academic.oup.com/jid/issue/225/3

 

COVID-2019
Infants Younger Than 6 Months Infected With SARS-CoV-2 Show the Highest Respiratory Viral Loads
Valeria Ochoa, Fernando Erra Díaz, Ezequiel Ramirez, María Clara Fentini, Mauricio Carobene …
The Journal of Infectious Diseases, Volume 225, Issue 3, 1 February 2022, Pages 392–395, https://doi.org/10.1093/infdis/jiab577

No Consistent Evidence of Decreased Exposure to Varicella-Zoster Virus Among Older Adults in Countries with Universal Varicella Vaccination

Posted on by

Journal of Infectious Diseases
Volume 225, Issue 3, 1 February 2022
https://academic.oup.com/jid/issue/225/3

 

VACCINES
Editor’s Choice
No Consistent Evidence of Decreased Exposure to Varicella-Zoster Virus Among Older Adults in Countries with Universal Varicella Vaccination
Stephane Carryn, Brigitte Cheuvart, Michael Povey, Alemnew F Dagnew, Rafael Harpaz …
The Journal of Infectious Diseases, Volume 225, Issue 3, 1 February 2022, Pages 413–421, https://doi.org/10.1093/infdis/jiab500
By repurposing humoral and cell-mediated immunogenicity data from a large multinational trial enrolling adults aged ≥50 years, we found no consistent evidence of differences in varicella-zoster virus exposure between countries with widely circulating varicella versus countries with universal vaccination.

Effectiveness of Human Papillomavirus (HPV) Vaccination Against Penile HPV Infection in Men Who Have Sex With Men and Transgender Women

Posted on by

Journal of Infectious Diseases
Volume 225, Issue 3, 1 February 2022
https://academic.oup.com/jid/issue/225/3

 

Effectiveness of Human Papillomavirus (HPV) Vaccination Against Penile HPV Infection in Men Who Have Sex With Men and Transgender Women
Rachel L Winer, John Lin, Troy D Querec, Elizabeth R Unger, Joshua E Stern …
The Journal of Infectious Diseases, Volume 225, Issue 3, 1 February 2022, Pages 422–430, https://doi.org/10.1093/infdis/jiab390
Penile quadrivalent human papillomavirus (HPV) vaccine–type HPV prevalence was lower among young men who have sex with men (MSM) self-reporting HPV vaccination at age ≤18 years than among MSM with no or unknown vaccination. Results suggest that HPV vaccination is effective against penile HPV infections when administered to MSM aged ≤18 years.

Universal Infant Hepatitis B Virus (HBV) Vaccination for 35 Years: Moving Toward the Eradication of HBV

Posted on by

Journal of Infectious Diseases
Volume 225, Issue 3, 1 February 2022
https://academic.oup.com/jid/issue/225/3

 

Universal Infant Hepatitis B Virus (HBV) Vaccination for 35 Years: Moving Toward the Eradication of HBV
Kai-Chi Chang, Mei-Hwei Chang, Huey-Ling Chen, Jia-Feng Wu, Chin-Hao Chang …
The Journal of Infectious Diseases, Volume 225, Issue 3, 1 February 2022, Pages 431–435, https://doi.org/10.1093/infdis/jiab401
Universal hepatitis B virus (HBV) vaccination effectively prevented chronic HBV infection. High vaccination coverage, comprehensive screening, and antiviral agents for pregnant mothers are essential to eliminate its perinatal transmission and for future elimination.

Redistribution of critical drugs in shortage during the first wave of COVID-19 in France: from operating theaters to intensive care units

Posted on by

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 02 Apr 2022]

 

Redistribution of critical drugs in shortage during the first wave of COVID-19 in France: from operating theaters to intensive care units
Tension in the supply of highly consumed drugs for patients with COVID-19 (propofol, midazolam, curares) led the French government to set up a centralized supply of hospitals with distribution based on the num…
Authors: Claire Chapuis, Rémy Collomp, Laura Albaladejo, Hugo Terrisse, Stéphane Honoré, Jean-Luc Bosson, Pierrick Bedouch and Pierre Albaladejo
Citation: Journal of Pharmaceutical Policy and Practice 2022 15:28
Content type: Research Published on: 1 April 2022

Assessing public knowledge, attitudes and determinants of third COVID-19 vaccine booster dose acceptance: current scenario and future perspectives

Posted on by

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 02 Apr 2022]

 

Assessing public knowledge, attitudes and determinants of third COVID-19 vaccine booster dose acceptance: current scenario and future perspectives
People with weakened immune systems may not develop adequate protection after taking two doses of the mRNA-combined COVID-19 vaccine. The additional dose may improve the level of protection against Covid-19.
Authors: Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Faris El-Dahiyat, Maimona Jairoun, Moyad Shahwan, Mena Al Ani, Mustafa Habeb and Zaheer-Ud-Din Babar
Citation: Journal of Pharmaceutical Policy and Practice 2022 15:26
Content type: Research Published on: 28 March 2022

Why COVID vaccines for young children (5–11 years) are not essential at this moment in time?

Posted on by

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 02 Apr 2022]

 

Why COVID vaccines for young children (5–11 years) are not essential at this moment in time?
The Joint Committee on Vaccination and Immunisation (JCVI) in UK has recently advised that COVID vaccines in 5–11-year-old children is non-essential. This has created an outrage among some healthcare professio…
Authors: Hamid A. Merchant
Citation: Journal of Pharmaceutical Policy and Practice 2022 15:25
Content type: Commentary Published on: 28 March 2022

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

Posted on by

The Lancet
Apr 02, 2022 Volume 399 Number 10332 p1279-1358, e20-e29
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Tommy Nyberg, et al. COVID-19 Genomics UK (COG-UK) consortium,
Open Access

Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India

Posted on by

The Lancet
Apr 02, 2022 Volume 399 Number 10332 p1279-1358, e20-e29
https://www.thelancet.com/journals/lancet/issue/current

 

Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
Akash Khobragade, et al. on behalf of the ZyCoV-D phase 3 Study Investigator Group

A roadmap of recovery for the COVID generation

Posted on by

The Lancet Child & Adolescent Health
Apr 2022 Volume 6 Number 4 p215-278, e13-e15
https://www.thelancet.com/journals/lanchi/issue/current

 

Editorial
A roadmap of recovery for the COVID generation
The Lancet Child & Adolescent Health
… The pandemic has had wide-ranging and long-lasting effects on young people, but children’s developmental plasticity and resilience give us room for optimism. As the world moves into the next phase of pandemic recovery and living with COVID-19, we must grasp this opportunity to support every child to catch up and thrive. The Lancet Child & Adolescent Health will be publishing a Commission to build a roadmap of recovery for this COVID generation. We call for collaborators and research from all aspects of child and adolescent health—particularly from our colleagues in development, social science, and adolescent health—to join us.

Global, regional, and national minimum estimates of children affected by COVID-19-associated orphanhood and caregiver death, by age and family circumstance up to Oct 31, 2021: an updated modelling study

Posted on by

The Lancet Child & Adolescent Health
Apr 2022 Volume 6 Number 4 p215-278, e13-e15
https://www.thelancet.com/journals/lanchi/issue/current

 

Articles
Global, regional, and national minimum estimates of children affected by COVID-19-associated orphanhood and caregiver death, by age and family circumstance up to Oct 31, 2021: an updated modelling study
H Juliette T Unwin,et al.
Open Access

Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study

Posted on by

Lancet Global Health
Apr 2022 Volume 10 Number 4 e448-e584
https://www.thelancet.com/journals/langlo/issue/current

 

Articles
Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study
Yusuke Shimakawa,et al.

Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses

Posted on by

Lancet Infectious Diseases
Apr 2022 Volume 22 Number 4p 427-562, e101-e127
https://www.thelancet.com/journals/laninf/issue/current

 

Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses
Ramachandran Thiruvengadam, et al. on behalf of the Department of Biotechnology India Consortium for COVID-19 research

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials

Posted on by

Lancet Infectious Diseases
Apr 2022 Volume 22 Number 4p 427-562, e101-e127
https://www.thelancet.com/journals/laninf/issue/current

 

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials
Gang Zeng, et al.

Mass drug administration of ivermectin and dihydroartemisinin–piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia

Posted on by

Lancet Infectious Diseases
Apr 2022 Volume 22 Number 4p 427-562, e101-e127
https://www.thelancet.com/journals/laninf/issue/current

 

Mass drug administration of ivermectin and dihydroartemisinin–piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia
Edgard D Dabira, et al.

Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial

Posted on by

Lancet Infectious Diseases
Apr 2022 Volume 22 Number 4p 427-562, e101-e127
https://www.thelancet.com/journals/laninf/issue/current

 

Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial
Ganesh Kumar Rai, et al.

Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort study

Posted on by

Lancet Public Health
Apr 2022 Volume 7 Number 4 e291-e390
https://www.thelancet.com/journals/lanpub/issue/current

 

Articles
Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort study
Luis C Berrocal-Almanza, et al

COVID-19 vaccine coverage and factors associated with vaccine uptake among 23 247 adults with a recent history of homelessness in Ontario, Canada: a population-based cohort study

Posted on by

Lancet Public Health
Apr 2022 Volume 7 Number 4 e291-e390
https://www.thelancet.com/journals/lanpub/issue/current

 

COVID-19 vaccine coverage and factors associated with vaccine uptake among 23 247 adults with a recent history of homelessness in Ontario, Canada: a population-based cohort study
Salimah Z Shariff, et al.

SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys

Posted on by

Lancet Respiratory Medicine
Apr 2022 Volume 10 Number 4 p313-420, e34-e43
https://www.thelancet.com/journals/lanres/issue/current

 

Articles
SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys
Marc Chadeau-Hyam, et al. in collaboration with the COVID-19 Genomics UK consortium
Open Access

Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study

Posted on by

Lancet Respiratory Medicine
Apr 2022 Volume 10 Number 4 p313-420, e34-e43
https://www.thelancet.com/journals/lanres/issue/current

 

Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study
Ruvim Izikson, et al.

COVID-19 prevention behaviors, trust, and intent to vaccinate among youth at risk for HIV

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 02 Apr 2022]

 

Research Article
COVID-19 prevention behaviors, trust, and intent to vaccinate among youth at risk for HIV
Joan Christodoulou, Anne E. Fehrenbacher, Elizabeth H. Shaw, Eleanor M. Vincent, Jessica L. Saleska
Research Article | published 31 Mar 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0266321

COVID-19 vaccine hesitancy among marginalized populations in the U.S. and Canada: Protocol for a scoping review

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 02 Apr 2022]

 

COVID-19 vaccine hesitancy among marginalized populations in the U.S. and Canada: Protocol for a scoping review
Peter A. Newman, Luke Reid, Suchon Tepjan, Sophia Fantus, Kate Allan, Thabani Nyoni, Adrian Guta, Charmaine C. Williams
Study Protocol | published 31 Mar 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0266120